FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1
Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.
Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.
Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1
Gaucher disease is rare and has signs and symptoms that can be confused with those of many other diseases. However, some tests allow the definitive diagnosis of the disease.
Olet poistumassa Sivustolta campus.sanofi/fi. Sanofi ei ole vastuussa tämän ulkoisen verkkoSivuston sisällöstä.